Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | CD44 | P16070 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2250625 | 0.84 | — | — | |
| SCHEMBL4267995 | 0.79 | CYP1A2 (0.52) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL668081 | 0.71 | CYP1A2 (0.48) | CYP1A2CYP2A6ALDH1A1TSHR | |
| SCHEMBL386156 | 0.71 | CYP1A2 (0.55) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL668494 | 0.71 | CYP1A2 (0.42) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL455151 | 0.71 | ALDH1A1 (0.41) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL465027 | 0.71 | CYP1A2 (0.36) | CYP1A2CYP2A6ALDH1A1TSHR | |
| SCHEMBL2285983 | 0.71 | CA1 (0.42) | ALDH1A1TSHRCA1CA2CA7 | |
| SCHEMBL20973057 | 0.67 | CYP2A6 (0.42) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL70280 | 0.67 | CYP2A6 (0.31) | CYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2746271-B1 | Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules | TOSOH CORP (JP) | 2016-08-17 | — | — | EP | disclosed |
| EP-2746271-A1 | Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules | Tosoh Corporation (JP) | 2014-06-25 | — | — | EP | disclosed |
| EP-2141158-B1 | PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | TOSOH CORP (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-8569485-B2 | Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component | TOSOH CORPORATION (JP) | 2013-10-29 | — | — | US | disclosed |
| US-20120313090-A1 | PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2012-12-13 | — | — | US | disclosed |
| EP-1930329-B1 | 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT | TOSOH CORP (JP) | 2012-10-24 | — | — | EP | disclosed |
| US-8268997-B2 | Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component | TOSOH CORPORATION (JP) | 2012-09-18 | — | — | US | disclosed |
| US-7994316-B2 | 1,3,5-triazine derivative, production method thereof and organic electroluminescence device comprising this as a composing component | TOSOH CORPORATION (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100249406-A1 | PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | TOSOH CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| EP-2141158-A1 | PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | Tosoh Corporation (JP) | 2010-01-06 | — | — | EP | disclosed |
| US-20090281311-A1 | 1,3,5-TRIAZINE DERIVATIVE, PRODUCTION METHOD THEREOF AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THIS AS A COMPOSING COMPONENT | TOSOH CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-1930329-A1 | 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT | Tosoh Corporation (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249406-A1 | PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | H1-5, H1-4, H1-2 | CYP1A2 227/4885CYP2A6 2269/4885ALDH1A1 1313/4885 |
| US-20090281311-A1 | 1,3,5-TRIAZINE DERIVATIVE, PRODUCTION METHOD THEREOF AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THIS AS A COMPOSING COMPONENT | KCNJ2, KCNA4, KCNJ4 | CYP1A2 459/4885CYP2A6 2133/4885ALDH1A1 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.